Systemic Immune Inflammation Index as High-Risk Retinoblastoma Survival Predictor.

Malino IY, Chozie NA, Kadim M, Pudjiadi AH, Supriyadi E, Sjakti HA

Open source

DOI
10.31557/apjcp.2026.27.8.2959
Published
2026 Aug 1
Container
Asian Pacific journal of cancer prevention : APJCP
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.31557/apjcp.2026.27.8.2959,
  title = {Systemic Immune Inflammation Index as High-Risk Retinoblastoma Survival Predictor.},
  author = {Malino IY and Chozie NA and Kadim M and Pudjiadi AH and Supriyadi E and Sjakti HA},
  year = {2026},
  journal = {Asian Pacific journal of cancer prevention : APJCP},
  doi = {10.31557/apjcp.2026.27.8.2959},
  url = {https://doi.org/10.31557/apjcp.2026.27.8.2959}
}

RIS

TY  - JOUR
TI  - Systemic Immune Inflammation Index as High-Risk Retinoblastoma Survival Predictor.
AU  - Malino IY
AU  - Chozie NA
AU  - Kadim M
AU  - Pudjiadi AH
AU  - Supriyadi E
AU  - Sjakti HA
PY  - 2026
JO  - Asian Pacific journal of cancer prevention : APJCP
DO  - 10.31557/apjcp.2026.27.8.2959
UR  - https://doi.org/10.31557/apjcp.2026.27.8.2959
ER  - 

APA

IY, M., NA, C., M, K., AH, P., E, S., & HA, S. (2026). Systemic Immune Inflammation Index as High-Risk Retinoblastoma Survival Predictor.. Asian Pacific journal of cancer prevention : APJCP. https://doi.org/10.31557/apjcp.2026.27.8.2959

Source records